ImmuCell Corporation Debt Instrument, Fair Value Disclosure
ImmuCell Corporation (ICCC) had Debt Instrument, Fair Value Disclosure of $8.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-08-13
- 2026-06-30: Debt Instrument, Fair Value Disclosure $8.30M.
- 2026-03-31: Debt Instrument, Fair Value Disclosure $8.70M.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $9.10M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $8.30M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.70M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.10M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |